Toxicokinetic and mass balance of morpholine in rats.

N-nitrosation N-nitrosomorpholine Toxicokinetic endogenous morpholine oral exposure

Journal

Xenobiotica; the fate of foreign compounds in biological systems
ISSN: 1366-5928
Titre abrégé: Xenobiotica
Pays: England
ID NLM: 1306665

Informations de publication

Date de publication:
May 2023
Historique:
pubmed: 11 7 2023
medline: 11 7 2023
entrez: 11 7 2023
Statut: ppublish

Résumé

Morpholine (MOR) has a broad spectrum of use and represents high risk of human exposure. Ingested MOR can undergo endogenous N-nitrosation in the presence of nitrosating agents forming N-nitrosomorpholine (NMOR), classified as possible human carcinogen by the International Agency for Research on Cancer.In this study, we evaluated the MOR toxicokinetics in six groups of male Sprague-Dawley rats orally exposed to 14C-radiolabelled MOR and NaNO2. The major urinary metabolite of MOR, N-nitrosohydroxyethylglycine (NHEG), was measured through HPLC as an index of endogenous N-nitrosation. Mass balance and toxicokinetic profile of MOR were determined by measuring radioactivity in blood/plasma and excreta.MOR reached maximum blood concentration 30 minutes after administration. Elimination rate was rapid (70% in 8h). Most of the radioactivity was excreted in the urine (80.9 ± 0.5%) and unchanged 14C-MOR was the main compound excreted in the urine (84% of the dose recovered). 5.8% of MOR is not absorbed and/or was not recovered.Endogenous nitrosation of MOR was demonstrated by the detection of NHEG. The maximum conversion rate found was 13.3 ± 1.2% and seems to be impacted by the MOR/NaNO2 ratio.These results help refining our knowledge of the endogenous production of NMOR, a possible human carcinogen.

Identifiants

pubmed: 37432873
doi: 10.1080/00498254.2023.2234487
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

412-420

Auteurs

Aleksandra Piotrowski (A)

EDF - Industrial Toxicology Division at EDF, General Direction of Safety and Health, Paris, France.

Saïd Kinani (S)

EDF R&D - National Hydraulics and Environment Laboratory, Paris, France.

Fabrice Nesslany (F)

ERBC Group. Chemin de Montifault, Baugy, France.

Nicolas Aubert (N)

Charles River Laboratories Evreux, Saint-Germain-Nuelle, France.

Sylvaine Ronga (S)

EDF - Medical Studies Department, General Direction of Safety and Health, Paris, France.

Magali Boize (M)

EDF Purchasing Department, Paris, France.

Salma Achawi (S)

EDF - Nuclear Fleet and Environment Engineering Division, Villeurbanne, France.

Pierre-André Cabanes (PA)

EDF - Medical Studies Department, General Direction of Safety and Health, Paris, France.

Classifications MeSH